These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis. Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769 [TBL] [Abstract][Full Text] [Related]
5. Do we need a new vaccine to control the re-emergence of pertussis? Mills KH; Ross PJ; Allen AC; Wilk MM Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284 [TBL] [Abstract][Full Text] [Related]
6. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Denoƫl P; Godfroid F; Guiso N; Hallander H; Poolman J Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273 [TBL] [Abstract][Full Text] [Related]
7. Acellular pertussis vaccines in China. Wang L; Lei D; Zhang S Vaccine; 2012 Nov; 30(50):7174-8. PubMed ID: 23084855 [TBL] [Abstract][Full Text] [Related]
8. Possible options for new pertussis vaccines. Meade BD; Plotkin SA; Locht C J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868 [TBL] [Abstract][Full Text] [Related]
9. Systematic review of the effects of pertussis vaccines in children. Simondon F Vaccine; 2004 Aug; 22(23-24):2965. PubMed ID: 15297044 [No Abstract] [Full Text] [Related]
10. Changing pertussis epidemiology: everything old is new again. Clark TA J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532 [TBL] [Abstract][Full Text] [Related]
11. Priming with whole-cell versus acellular pertussis vaccine. Liko J; Robison SG; Cieslak PR N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023 [No Abstract] [Full Text] [Related]
16. Immune responses to pertussis vaccines and disease. Edwards KM; Berbers GA J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958 [TBL] [Abstract][Full Text] [Related]
17. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397 [TBL] [Abstract][Full Text] [Related]
18. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan. Pichichero ME; Decker MD Biologicals; 2005 Mar; 33(1):59. PubMed ID: 15713557 [No Abstract] [Full Text] [Related]
19. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021 [TBL] [Abstract][Full Text] [Related]
20. Has the change to acellular pertussis vaccine improved or worsened pertussis control? Halperin SA; De Serres G CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952 [No Abstract] [Full Text] [Related] [Next] [New Search]